CalciMedica, Inc.

CALC
$0.57 (- $0.01 - 1.72%)
Last updated: 2026-08-24 03:42 UTC
CALC Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS38942Q2021
CUSIP38942Q202
Market Price0.57
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-1.62
Market Cap$88.3M
Book Value-0.02
Price to Book-322.632
Beta1.12
52w High6.4
52w Low1.42
Next Earnings DateN/A

CalciMedica, Inc. trades under ticker CALC on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US38942Q2021, CUSIP 38942Q202. Also searched as CalciMedica.

Related researchCALC stock priceCALC share price38942Q202CalciMedica stockCalciMedica share price
About the Company
CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops Auxora for the treatment of acute ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory indications. The company is based in La Jolla, California.
Price History